Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36a pseudogene 33 (RPL36AP33) is a human processed pseudogene derived from the ribosomal protein L36a gene family. Pseudogenes like RPL36AP33 are segments of DNA that resemble functional genes but typically lack coding potential and are not translated into functional proteins. RPL36AP33 does not encode a product with intrinsic biological activity and is not considered relevant to drug discovery or therapy. Like other ribosomal protein pseudogenes, it exists as a result of evolutionary duplication and subsequent loss of function[1][2][4]. Note: If you are seeking information about the *functional* ribosomal protein L36a (RPL36A) or its protein product, this is a distinct gene and serves as a structural component of the large (60S) ribosomal subunit, but the *pseudogene* RPL36AP33 itself does not share this role[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 33 (RPL36AP33).